esketamine has been researched along with Affective Disorders in 2 studies
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 2 (100.00) | 2.80 |
Authors | Studies |
---|---|
Cao, B; Cha, DS; Gill, H; Ho, R; Kratiuk, K; Lee, Y; Lipsitz, O; Lui, LMW; Mansur, RB; McIntyre, RS; Nasri, F; Ng, J; Rodrigues, NB; Rosenblat, JD; Subramaniapillai, M; Teopiz, KM; Xiong, J | 1 |
Cao, B; Ceban, F; Chau, EH; Gill, H; Ho, RC; Kratiuk, K; Kumar, A; Lee, JG; Lee, Y; Lin, K; Lipsitz, O; Lui, LMW; Mansur, RB; McIntyre, RS; Nasri, F; Rodrigues, NB; Rosenblat, JD; Subramaniapillai, M; Swainson, J | 1 |
2 review(s) available for esketamine and Affective Disorders
Article | Year |
---|---|
Ketamine-induced urological toxicity: potential mechanisms and translation for adults with mood disorders receiving ketamine treatment.
Topics: Adult; Antidepressive Agents; Depressive Disorder, Treatment-Resistant; Humans; Ketamine; Mood Disorders | 2021 |
Prevention and Management of Common Adverse Effects of Ketamine and Esketamine in Patients with Mood Disorders.
Topics: Administration, Intranasal; Administration, Intravenous; Antidepressive Agents; Anxiety; Disease Management; Drug-Related Side Effects and Adverse Reactions; Gastrointestinal Diseases; Humans; Ketamine; Mood Disorders; Nausea | 2021 |